These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 15081565

  • 1. The viscosity of fibrinogen subfractions and of EDTA denatured fibrinogen do not differ from that of native fibrinogen.
    Jensen T, Halvorsen S, Godal HC, Sandset PM, Skjønsberg OH.
    Thromb Res; 2004; 113(1):51-6. PubMed ID: 15081565
    [Abstract] [Full Text] [Related]

  • 2. Fibrinogen heterogeneity in homozygous plasminogen deficiency type I: further evidence that plasmin is not involved in formation of LMW- and LMW'-fibrinogen.
    Dempfle CE, Pfitzner SA, Schott D, Niessen KH, Heene DL.
    Thromb Haemost; 1997 May; 77(5):879-83. PubMed ID: 9184396
    [Abstract] [Full Text] [Related]

  • 3. Effect of magnesium on fibrin formation from lower molecular weight (LMW) fibrinogen.
    Lipinski B, Lipinska I.
    Magnes Res; 2000 Dec; 13(4):233-7. PubMed ID: 11153893
    [Abstract] [Full Text] [Related]

  • 4. Influence of the sample matrix on the stability of beta-CTX at room temperature for 24 and 48 hours.
    Lippi G, Brocco G, Salvagno GL, Montagnana M, Guidi GC, Schmidt-Gayk H.
    Clin Lab; 2007 Dec; 53(7-8):455-9. PubMed ID: 17821951
    [Abstract] [Full Text] [Related]

  • 5. Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma.
    Holm B, Nilsen DW, Kierulf P, Godal HC.
    Thromb Res; 1985 Jan 01; 37(1):165-76. PubMed ID: 3983897
    [Abstract] [Full Text] [Related]

  • 6. Quantitation of the three normally-occurring plasma fibrinogens in health and during so-called "acute phase" by SDS electrophoresis of fibrin obtained from EDTA-plasma.
    Holm B, Godal HC.
    Thromb Res; 1984 Aug 01; 35(3):279-90. PubMed ID: 6431629
    [Abstract] [Full Text] [Related]

  • 7. Duvernoy's gland secretion of Philodryas patagoniensis from the northeast of Argentina: its effects on blood coagulation.
    Peichoto ME, Leiva LC, Guaimás Moya LE, Rey L, Acosta O.
    Toxicon; 2005 Mar 15; 45(4):527-34. PubMed ID: 15733575
    [Abstract] [Full Text] [Related]

  • 8. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system.
    Sanchez J, Elgue G, Larsson R, Nilsson B, Olsson P.
    Thromb Res; 2008 Mar 15; 122(2):257-63. PubMed ID: 18177925
    [Abstract] [Full Text] [Related]

  • 9. Polymerization properties of two normally circulating fibrinogens, HMW and LMW. Evidence that the COOH-terminal end of the a-chain is of importance for fibrin polymerization.
    Holm B, Brosstad F, Kierulf P, Godal HC.
    Thromb Res; 1985 Sep 01; 39(5):595-606. PubMed ID: 4082102
    [Abstract] [Full Text] [Related]

  • 10. Fibrinogen heterogeneity in cancer, in occlusive vascular disease, and after surgical procedures.
    Lipinska I, Lipinski B, Gurewich V, Hoffmann KD.
    Am J Clin Pathol; 1976 Dec 01; 66(6):958-66. PubMed ID: 998569
    [Abstract] [Full Text] [Related]

  • 11. Purification and characterization of Atlantic salmon (Salmo salar) fibrinogen.
    Manseth E, Skjervold PO, Fjaera SO, Brosstad FR, Bjørnson S, Flengsrud R.
    Comp Biochem Physiol B Biochem Mol Biol; 2004 Jun 01; 138(2):169-74. PubMed ID: 15193272
    [Abstract] [Full Text] [Related]

  • 12. Evidence that changes in fibrinogen quality during acute phase reactions are of major importance for the amount of heparin precipitable fraction (HPF).
    Holm B, Godal HC.
    Thromb Res; 1985 Aug 15; 39(4):449-58. PubMed ID: 4049325
    [Abstract] [Full Text] [Related]

  • 13. Plasma ascorbic acid preparation and storage for epidemiological studies using TCA precipitation.
    Salminen I, Alfthan G.
    Clin Biochem; 2008 Jun 15; 41(9):723-7. PubMed ID: 18371942
    [Abstract] [Full Text] [Related]

  • 14. Change of viscoelastic property and morphology of fibrin affected by antithrombin III and heparin: QCM-Z and AFM study.
    Jung H, Tae G, Kim YH, Johannsmann D.
    Colloids Surf B Biointerfaces; 2009 Jan 01; 68(1):111-9. PubMed ID: 19004623
    [Abstract] [Full Text] [Related]

  • 15. Interactions of human blood platelets with three circulating plasma fibrinogens of different molecular weights.
    Thorsen LI, Holm B, Brosstad F, Solum NO.
    Thromb Res; 1987 Sep 15; 47(6):683-92. PubMed ID: 3686483
    [Abstract] [Full Text] [Related]

  • 16. Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels.
    Selmeci L, Székely M, Soós P, Seres L, Klinga N, Geiger A, Acsády G.
    Free Radic Res; 2006 Sep 15; 40(9):952-8. PubMed ID: 17015275
    [Abstract] [Full Text] [Related]

  • 17. Plasma viscosity: a forgotten variable.
    Késmárky G, Kenyeres P, Rábai M, Tóth K.
    Clin Hemorheol Microcirc; 2008 Sep 15; 39(1-4):243-6. PubMed ID: 18503132
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Polyethylene oxide surfaces of variable chain density by chemisorption of PEO-thiol on gold: adsorption of proteins from plasma studied by radiolabelling and immunoblotting.
    Unsworth LD, Sheardown H, Brash JL.
    Biomaterials; 2005 Oct 15; 26(30):5927-33. PubMed ID: 15958239
    [Abstract] [Full Text] [Related]

  • 20. Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance.
    Solá E, Vayá A, Simó M, Hernández-Mijares A, Morillas C, España F, Estellés A, Corella D.
    Clin Hemorheol Microcirc; 2007 Oct 15; 37(4):309-18. PubMed ID: 17942983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.